title: The need for greater involvement of regulatory agencies in assessing adverse drug reactions.
authors.affiliation: McGill University, Montreal, Que. allan.sniderman@muhc.mcgill.ca
authors.forename: A D
authors.initials: AD
authors.lastname: Sniderman
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D001067:Appetite Depressants / Q000009:adverse effects; D004345:Drug Industry; D005277:Fenfluramine / Q000009:adverse effects; D006077:Government Agencies / Q000458:organization & administration*; D006349:Heart Valve Diseases / Q000139:chemically induced; D006801:Humans; D010645:Phentermine / Q000009:adverse effects; D018490:Serotonin Agents / Q000009:adverse effects
chemical_list: D001067:Appetite Depressants; D018490:Serotonin Agents; D005277:Fenfluramine; D010645:Phentermine